(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Jan 31, 2013
0
0
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...
Apr 28, 2015
0
3
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Mar 11, 2013
0
0
Competitive sports can be a lot of fun for kids and teens, but starting a new season requires some planning.
Jul 21, 2023
0
10
According to the Centers for Disease Control and Prevention, two million people become infected with antibiotic resistant bacteria each year, leading to at least 23,000 deaths. And these infections cost a lot – US$20billion ...
Feb 9, 2015
0
8
(AP)—The Olympics have Baron Pierre de Coubertin, the founder of the modern games. The Paralympics have Sir Ludwig Guttmann.
Aug 28, 2012
0
0
A study by researchers at the University of North Carolina Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost savings for a generic version of an orally administered cancer treatment ...
Sep 11, 2017
0
0
A U.S. court on Wednesday invalidated the key patent for one of Pfizer's most lucrative medicines, potentially opening the door for cheaper generic versions 18 months sooner than expected and cutting into the drugmaker's ...
Mar 12, 2014
0
0
Australia's medical and health sciences are leading the country in research quality, according to the Excellence in Research for Australia (ERA) report.
Dec 6, 2012
0
0
Coverage under President Barack Obama's health care law won't be cheap, but two independent private studies show that cost-conscious consumers hunting for lower premiums will have plenty of options.
Sep 4, 2013
0
0
